Kezdőlap・Részvénylista・Vaxcyte Inc

Vaxcyte Inc

Nyitva

SzektorEgészségügy

58.03 -1.01

Vétel Eladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

56.95

Maximum

60.14

Fő mutatók
By Trading Economics
Bevétel	-284M -605M
Egy részvényre jutó nyereség	-1.97
Munkavállalók	507
EBITDA	22M -292M

Ajánlások
By TipRanks
Ajánlások	Erős vétel
12 hónapos előrejelzés	+94.24% upside

Osztalékok
By Acuity
Következő eredményjelentés	2026. nov. 2.

Piaci statisztika
By TradingEconomics
Piaci kapitalizáció	944M 8.7B
Előző nyitás	59.04
Előző zárás	58.03

Hangulat hírek alapján

By Acuity

50%

171 / 340 Rangsor szerint Healthcare

Vaxcyte Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 12. 19:46 UTC

Vaxcyte Inc shares are higher today, supported by broader market gains following positive sentiment from the recent inflation report. The stock remains above its 20-day moving average.

2026. aug. 11. 23:11 UTC

Vaxcyte Inc shares are higher in after-market trading, reflecting positive momentum despite no specific news driving the price action.

2026. aug. 10. 19:56 UTC

Vaxcyte Inc shares are higher, continuing gains since Friday's close, reaching a peak earlier in the session. No specific news was identified for the move.

2026. aug. 7. 21:01 UTC

Vaxcyte Inc shares are lower in after-market hours, continuing a weak trading session without any specific news to explain the decline.

2026. aug. 6. 20:03 UTC

News

Vaxcyte reports a net loss of $284.3 million for Q2. Shares are trading higher as the company anticipates key Phase 3 trial data in 2027.

2026. aug. 5. 19:16 UTC

Vaxcyte Inc. shares are higher today, aligning with broader market trends, despite no specific news identified. The stock remains near its one-month range low.

2026. aug. 4. 20:21 UTC

Vaxcyte Inc. shares are lower in after-market trading, remaining flat since Tuesday's close and positioned below its 20-day moving average.

2026. aug. 3. 19:46 UTC

Vaxcyte Inc's shares are lower today, continuing a decline since Friday. The stock is trading near the lower end of its one-month range.

2026. júl. 31. 19:56 UTC

Correlated Moves

Shares lower amid broader sector sentiment; SPDR S&P Biotech ETF declines.

2026. júl. 30. 18:52 UTC

Vaxcyte Inc's shares are higher today amid strong buying activity, reaching an intraday high but remain below the 20-day moving average.

2026. júl. 29. 18:23 UTC

Vaxcyte Inc is lower in Wednesday's session, breaking a trend of higher daily closes. No specific news was identified to explain the decline.

2026. júl. 28. 18:46 UTC

Vaxcyte Inc. shares are trading lower amid broader market trends and volatility, remaining below the 20-day moving average as bond yields decline.

2026. júl. 27. 19:46 UTC

Vaxcyte Inc shares are trading higher today, despite earlier declines and without specific company news. Broader market volatility is influenced by falling crude oil prices.

2026. júl. 23. 19:16 UTC

Vaxcyte Inc shares are lower today amid a broader decline in tech stocks following earnings reports from Alphabet and Tesla. No specific news was identified.

2026. júl. 21. 18:26 UTC

Vaxcyte Inc is trading higher today, continuing its advance since Monday's close. This movement occurs despite concerns over rising treasury yields and geopolitical tensions.

Társak összehasonlítása

Árváltozás

Vaxcyte Inc Előrejelzés

Célár

By TipRanks

94.24% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 114.33 USD 94.24%

Magas 163 USD

Alacsony 75 USD

7 Wall Street elemző 12 hónapos célárain alapulva a(z)Vaxcyte Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

7 ratings

Vétel

Tartás

Eladás

7 Wall Street elemző célárain alapulva a(z)Vaxcyte Inc termékhez az elmúlt 3 hónapban.

Hangulat

By Acuity

171 / 340 Rangsor szerint Egészségügy

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

Rólunk Vaxcyte Inc

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.